Apoptosis of human glioma cells in vitro and in vivo induced by a neutralizing antibody against human basic fibroblast growth factor

Journal of Neurosurgery

Volumn 85, Issue 6, 1996, Pages 1072-1077

  Murai, Nozomu ^a   Ueba, Tetsuya ^a   Takahashi, Jun A ^a   Yang, Hong Qiong ^a   Kikuchi, Haruhiko ^a   Hiai, Hiroshi ^a   Hatanaka, Masakazu ^a   Fukumoto, Manabu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

anti basic fibroblast growth factor antibody; apoptosis; human glioma; immunotherapy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL GROWTH; FIBROBLAST; GLIOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029906027     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.6.1072     Document Type: Article

References (51)

1. Abe T, Okamura K, Ono M, et al: Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis. J Clin Invest 92:54-61, 1993
2. Alderson LM, Castleberg RL, Harsh GR IV, et al: Human gliomas with wild-type p53 express bcl-2. Cancer Res 55: 999-1001, 1995
3. Araki S, Shimada Y, Kaji K, et al: Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun 168:1194-1200, 1990
4. Arends MJ, Morris RG, Wyllie AH: Apoptosis. The role of endonuclease. Am J Pathol 136:593-608, 1990
5. Baserga R: The insulin-like growth factor I receptor. A key to tumor growth? Cancer Res 55:249-252, 1995
6. Behl C, Winkler J, Bogdahn U, et al: Autocrine growth regulation in neuroectodermal tumors as detected with oligodeoxynucleotide antisense molecules. Neurosurgery 33:679-684, 1993
7. Conn G, Soderman DD, Schaeffer MT, et al: Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 87:1323-1327, 1990
8. Couldwell WT, Hinten DR, He S, et al: Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines. FEBS Lett 345:43-46, 1994
9. Deen DF, Chiarodo A, Grimm EA, et al: Brain tumor working group report on the 9th international conference on brain tumor research and therapy. J Neurooncol 16:243-272, 1993
10. Frankel RH, Bayona W, Koslow M, et al: p53 mutations in human malignant gliomas. Comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427-1433, 1992
11. Golstein P, Ojcius DM, Young DE: Cell death mechanisms and the immune system. Immunol Rev 121:29-65, 1991
12. Gospodarowicz D: Fibroblast growth factor. Chemical structure and biologic function. Clin Orthop 257:231-248, 1990
13. Gospodarowicz D, Ferrara N, Schweigerer L, et al: Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8:95-114, 1987
14. Gospodarowicz D, Neufeld G, Schweigerer L: Fibroblast growth factor: structural and biological properties. J Cell Physiol (Suppl 5): 15-26, 1987
15. Gross JL, Herblin WF, Dusak BA, et al: Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J Natl Cancer Inst 85:121-131, 1993
16. Gross JL, Morrison RS, Eidsvoog K, et al: Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth. J Neurosci Res 27:689-696, 1990
17. Hockenbery D, Nuñez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
18. Hori A, Sasada R, Matsutani E, et al: Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res 51: 6180-6184, 1991
19. Ishida Y, Agata Y, Shibahara K, et al: Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 11:3887-3895, 1992
20. Iwasaki K, Toms SA, Barnett GH, et al: Inhibitory effects of tamoxifen and tumor necrosis factor α on human glioblastoma cells. Cancer Immunol Immunother 40:228-234, 1995
21. Jones KD, Couldwell WT, Hinton DR, et al: Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells. Biochem Biophys Res Commun 205:1681-1687, 1994
22. Kondo S, Yin D, Aoki T, et al: bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells. Exp Cell Res 213:428-432, 1994
23. Kondo S, Yin D, Morimura T, et al: Combination therapy with cisplatin and nifedipine inducing apoptosis in multidrug-resistant human glioblastoma cells. J Neurosurg 82:469-474, 1995
24. Lane DP: A death in the life of p53. Nature 362:786-787, 1993
25. Lane DP: p53, guardian of the genome. Nature 358:15-16, 1992
26. Libermann TA, Friesel R, Jaye M, et al: An angiogenic growth factor is expressed in human glioma cells. EMBO J 6: 1627-1632, 1987
27. Libermann TA, Razon N, Bartal AD, et al: Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 44:753-760, 1984
28. Mercer WE, Shields MT, Amin M, et al: Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87: 6166-6170, 1990
29. Morrison RS: Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J Biol Chem 266: 728-734, 1991
30. Morrison RS, Giordano S, Yamaguchi F, et al: Basic fibroblast growth factor expression is required for clonogenic growth of human glioma cells. J Neurosci Res 34:502-509, 1993
31. Morrison RS, Gross JL, Herblin WF, et al: Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line. Cancer Res 50:2524-2529, 1990
32. Murphy PR, Guo JZ, Friesen HG: Messenger RNA stabilization accounts for elevated basic fibroblast growth factor transcript levels in a human astrocytoma cell line. Mol Endocrinol 4: 196-200, 1990
33. Murphy PR, Sato Y, Knee RS: Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol Endocrinol 6:877-884, 1992
34. Nistér M, Libermann T, Betsholtz C, et al: Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-α and their receptors in human malignant glioma cell lines. Cancer Res 48:3910-3918, 1988
35. Paulus W, Grothe C, Sensenbrenner M, et al: Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol 79:418-423, 1990
36. Redekop GJ, Naus CCG: Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. J Neurosurg 82:83-90, 1995
37. Sato Y, Murphy PR, Sato R, et al: Fibroblast growth factor release by bovine endothelial cells and human astrocytoma cells in culture is density dependent. Mol Endocrinol 3: 744-748, 1989
38. Tabuchi K, Fukuyama K, Mineta T, et al: Altered structure and expression of the p53 gene in human neuroepithelial tumors. Neurol Med Chir 32:725-732, 1992
39. Takahashi JA, Fukumoto M, Igarashi K, et al: Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 76:792-798, 1992
40. Takahashi JA, Fukumoto M, Kozai Y, et al: Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Lett 288:65-71, 1991
41. Takahashi JA, Mori H, Fukumoto M, et al: Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci USA 87:5710-5714, 1990
42. Takahashi JA, Suzui H, Yasuda Y, et al: Gene expression of fibroblast growth factor receptors in the tissues of human gliomas and meningiomas. Biochem Biophys Res Commun 177: 1-7, 1991
43. Tsujimoto Y: Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc Natl Acad Sci USA 86:1958-1962, 1989
44. Tsujimoto Y, Cossman J, Jaffe E, et al: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443, 1985
45. Ueba T, Nosaka T, Takahashi JA, et al: Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells. Proc Natl Acad Sci USA 91:9009-9013, 1994
46. Ueba T, Takahashi JA, Fukumoto M, et al: Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues. Neurosurgery 34:221-226, 1994
47. Vallbo C, Bergenheim T, Bergh A, et al: DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain - suggesting an apoptotic cell death. Br J Cancer 71:717-720, 1995
48. Weller M, Frei K, Groscurth P, et al: Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954-964, 1994
49. Williams GT, Smith CA, Spooncer E, et al: Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79, 1990
50. Yamaguchi F, Saya H, Bruner JM, et al: Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 91:484-488, 1994
51. Zhang W, Hara A, Murakawa T, et al: Effect of interferon-γ on ACNU-induced DNA damage and cytotoxicity in human glioblastoma cells. Neurol Med Chir 33:275-279, 1993